| cue reactivity |
phenotype |
5 |
5 |
cue reactivity test, cue-induced cocaine craving, cue-induced craving |
| Cufflinks |
drug |
2 |
2 |
|
| culture medium |
drug |
5 |
— |
medium |
| current age |
phenotype |
2 |
2 |
age, current age |
| current daily smoking |
phenotype |
2 |
1 |
current daily smoking |
| current depression |
phenotype |
3 |
— |
current MD, current depression, severity-related depression |
| current drinkers |
phenotype |
8 |
5 |
current alcohol problems, current drinker, current drinker status, current drinkers, current drinkers (consumed alcohol in the past 12 months), drank within the last 12 months |
| current sample |
cohort |
12 |
7 |
current study |
| current smoking |
phenotype |
20 |
15 |
cotinine-verified current smokers, current, current smoker, current smokers, current smokers in PLCO, current smoking, current smoking behavior, current smoking habits, current smoking prevalence, current smoking status, smokers, smoking, smoking cessation |
| current study |
cohort |
13 |
4 |
our article, our study, this study |
| CurrentStudy |
cohort |
2 |
1 |
this study |
| CUX2 |
gene |
3 |
3 |
Cutl2, Cux2, Cux2 cut-like homeobox 2, cut-like homeobox 2 |
| Cx3cr1 |
gene |
6 |
5 |
CX3CR1-GFP, CX3CR1eGFP, CX3CR1eGFP/+, CX3CR1eGFP/eGFP, Cx3cr1 |
| CXCR4 |
gene |
4 |
2 |
CD184 |
| Cxcr7 |
gene |
3 |
2 |
ACKR3, C-X-C chemokine receptor type 7, Cxcr7 |
| Cy3 |
drug |
6 |
2 |
|
| Cy5 |
drug |
6 |
1 |
|
| cyanamide |
drug |
2 |
2 |
ALDH inhibitor cyanamide |
| cyclic AMP |
drug |
2 |
— |
cAMP |
| cyclothiazide |
drug |
2 |
2 |
|
